Bruker Corporation (NASDAQ:BRKR) Stock Has Average Target Price of $58.57 According to Brokerages

Shares of Bruker Corporation (NASDAQ:BRKR) have received an average recommendation of “Moderate Buy” from the fourteen brokerages that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation, six have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $58.57.

BRKR has been the topic of several recent analyst reports. Stifel Nicolaus set a $50.00 target price on Bruker in a research report on Wednesday, August 5th. TD Cowen reissued a “hold” rating on shares of Bruker in a report on Wednesday, July 15th. Citigroup lowered their price target on Bruker from $60.00 to $53.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. The Goldman Sachs Group upgraded Bruker from a “strong sell” rating to a “strong-buy” rating in a research note on Monday, September 21st. Finally, Zacks Research lowered shares of Bruker from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 2nd.

Insider Activity

In other news, VP Mark Munch sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $52.87, for a total value of $105,740.00. Following the completion of the transaction, the vice president directly owned 134,806 shares in the company, valued at $7,127,193.22. This trade represents a 1.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 27.20% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Bruker

A number of large investors have recently bought and sold shares of the company. Wellington Management Group LLP acquired a new stake in Bruker during the 2nd quarter valued at approximately $1,365,000. Hsbc Holdings PLC purchased a new stake in shares of Bruker in the 2nd quarter valued at $5,252,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Bruker in the second quarter worth $4,536,000. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of Bruker in the second quarter worth $169,899,000. Finally, Legal & General Group Plc acquired a new stake in shares of Bruker in the second quarter worth $8,742,000. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Bruker Price Performance

NASDAQ BRKR opened at $58.84 on Friday. The firm’s fifty day simple moving average is $58.64 and its two-hundred day simple moving average is $52.75. The firm has a market capitalization of $8.96 billion, a P/E ratio of -84.06, a P/E/G ratio of 1.80 and a beta of 1.22. The company has a current ratio of 1.85, a quick ratio of 0.92 and a debt-to-equity ratio of 0.76. Bruker has a 12-month low of $32.37 and a 12-month high of $66.98.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.38 by $0.11. The firm had revenue of $838.50 million during the quarter, compared to analyst estimates of $853.57 million. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%. The business’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.32 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Analysts forecast that Bruker will post 2.12 EPS for the current fiscal year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 7th. Stockholders of record on Monday, September 21st were issued a $0.05 dividend. The ex-dividend date of this dividend was Monday, September 21st. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Bruker’s dividend payout ratio is currently -28.57%.

About Bruker

Bruker Corporation develops and manufactures scientific instruments, analytical systems and related software used to study materials, chemicals, biological samples and industrial products. Its customers include academic and government research institutions, pharmaceutical and biotechnology companies, hospitals, environmental laboratories and industrial manufacturers.

The company’s portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray instruments, microscopy and surface-analysis platforms, molecular spectroscopy systems, and analytical tools for proteomics, spatial biology, metabolomics and materials research.